Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Incidence and survival of pediatric and adult hepatocellular carcinoma, United States, 2001–2020

Cancer Epidemiology(2024)10.1016/j.canep.2024.102610Source: DataRank Database

Incidence and survival of pediatric and adult hepatocellular carcinoma, United States, 2001–2020 is a research paper published in Cancer Epidemiology (2024). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access12 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 2.91)OA: greenTopics (75)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

David A. Siegel ORCID,Shifan Dai ORCID,Trevor Thompson ORCID,Jennifer H. Foster ORCID,Erika J. di Pierro

Live enrichment

PubMed:38986355 PMC:PMC12409671 OpenAlex:https://openalex.org/W4400447738

NIH

Grant: T32GM136554

Intramural CDC HHS

Grant: CC999999

National Institutes of Health

Grant: 5T32GM136554-04

The Clinical Translational Research Certificate of Added Qualification Program

National Institute of General Medical Sciences

FWCI

2.91

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

greenLicense: Elsevier TDM

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12409671/pdf/nihms-2102495.pdf

publisherhttps://api.elsevier.com/content/article/PII:S1877782124000894?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1877782124000894?httpAccept=text/plain

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12409671/

Fields of Study

Hepatocellular Carcinoma Treatment and PrognosisAcute Lymphoblastic Leukemia researchHepatitis B Virus Studies03 medical and health sciences0302 clinical medicineHumansChildAdolescentUnited StatesChild, PreschoolIncidenceLiver NeoplasmsCarcinoma, HepatocellularInfantMaleFemaleYoung AdultAdultInfant, NewbornMiddle AgedSurvival RateRegistriesAged

MeSH Terms

AdolescentAdultAgedChildChild, PreschoolFemaleCarcinoma, HepatocellularHumansInfantInfant, NewbornLiver NeoplasmsMaleMiddle AgedRegistriesUnited StatesIncidenceSurvival RateYoung Adult

Keywords

MedicineHepatocellular carcinomaIncidence (geometry)Relative survivalEpidemiologyConfidence intervalDemographyProportional hazards modelPopulationLiver cancerRelative riskCancer registryInternal medicineEnvironmental healthSurvivalincidenceMaleAdultCarcinoma, HepatocellularAdolescentLiver NeoplasmsInfant, NewbornInfantMiddle AgedArticleUnited StatesSurvival RateYoung AdultChild, PreschoolHumansFemaleRegistriesChildAged

Sustainable Development Goals

SDG 3: 3. Good health